⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8145346 | 1.00 | — | — | |
| SCHEMBL12064988 | 1.00 | — | — | |
| SCHEMBL24741443 | 0.90 | — | — | |
| SCHEMBL5184661 | 0.90 | — | — | |
| SCHEMBL18658857 | 0.90 | — | — | |
| SCHEMBL14908536 | 0.88 | — | — | |
| SCHEMBL10037574 | 0.78 | — | — | |
| SCHEMBL359800 | 0.69 | — | — | |
| SCHEMBL28042158 | 0.69 | — | — | |
| SCHEMBL25045822 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111511725-A | Synthesis of 1:1:1 cocrystals of 1-cyano-2- (4-cyclopropyl-benzyl) -4- (β -D-glucopyranos-1-yl) -benzene, L-proline and water | 勃林格殷格翰维特梅迪卡有限公司 | 2020-08-07 | — | — | CN | claimed |
| CN-105153137-A | Preparation method of empagliflozin | SHANGHAI INST TECHNOLOGY | 2015-12-16 | — | — | CN | claimed |
| CN-119464281-A | SiRNA, siRNA conjugate or prodrug thereof for inhibiting DGAT2 gene expression, pharmaceutical composition and application | 北京福元医药股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119464279-A | SiRNA for inhibiting SMAD family member 3 expression, conjugate, pharmaceutical composition and application thereof | 北京福元医药股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-118421622-A | SiRNA for inhibiting angiopoietin-like protein 8 gene expression, conjugate, pharmaceutical composition and application thereof | 北京福元医药股份有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-117757790-A | siRNA for inhibiting SCAP gene expression, conjugate, pharmaceutical composition and application thereof | 北京福元医药股份有限公司 | 2024-03-26 | — | — | CN | disclosed |
| WO-2024054766-A2 | MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER | MITO BIOPHARMA, LLC (US) | 2024-03-14 | — | — | WO | disclosed |
| CN-117645995-A | SiRNA for inhibiting expression of asialoglycoprotein receptor gene, conjugate, pharmaceutical composition and application thereof | 北京福元医药股份有限公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-117070517-A | siRNA for inhibiting expression of angiotensinogen, conjugate, pharmaceutical composition and application thereof | 北京福元医药股份有限公司 | 2023-11-17 | — | — | CN | disclosed |
| WO-2023196409-A1 | DISCOVERY OF COVALENT EGFR INHIBITOR THROUGH CYSTEINE 775 | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2023-10-12 | — | — | WO | disclosed |
| CN-116769780-A | siRNA for inhibiting expression of complement factor B, conjugate and pharmaceutical composition thereof and use thereof | 北京福元医药股份有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-1572754-A | Method for producing organic compound by substituting halogen atoms | MITSUI CHEMICALS INC (JP) | 2005-02-02 | — | — | CN | disclosed |
| US-20040256743-A1 | Method for producing organic compound by substituting halogen atoms | MITSUI CHEMICALS, INC. (JP) | 2004-12-23 | — | — | US | disclosed |
| EP-1485387-A1 | CARBAMATES AS HIV PROTEASE INHIBITORS | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2004-12-15 | — | — | EP | disclosed |
| EP-1486479-A1 | Method for producing organic compounds by substituting halogen atoms | MITSUI CHEMICALS, INC. (JP) | 2004-12-15 | — | — | EP | disclosed |
| US-20040039016-A1 | HIV protease inhibitors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-02-26 | — | — | US | disclosed |
| WO-2003078438-A1 | CARBAMATES AS HIV PROTEASE INHIBITORS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2003-09-25 | — | — | WO | disclosed |
| EP-1088098-A2 | FITNESS ASSAY AND ASSOCIATED METHODS | UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND SOCIAL SERVICES (US) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999067254-A2 | MULTI-DRUG RESISTANT RETROVIRAL PROTEASE INHIBITORS AND USE THEREOF | THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-12-29 | — | — | WO | disclosed |
| WO-1999067417-A2 | FITNESS ASSAY AND ASSOCIATED METHODS | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-12-29 | — | — | WO | disclosed |